Department of Communicable Diseases, Interactive Research School for Health Affairs, Bharati Vidyapeeth (Deemed to be University), Pune, India.
Mankar Children Hospital, Pune, India.
Front Public Health. 2024 Sep 20;12:1354510. doi: 10.3389/fpubh.2024.1354510. eCollection 2024.
To understand the dynamics of dengue disease with special reference to (1) age (2) primary/secondary infections (3) serostatus and (4) serotypes examined during three consecutive years.
During 3 dengue seasons (2017-19), NS1/IgM ELISAs were used for dengue diagnosis in one of the 15 administrative wards of Pune City, India. Predefined symptoms were recorded at the time of diagnosis/hospitalization. IgG-capture ELISA (Panbio) was used to differentiate primary/secondary infections. DENV serotypes were determined for 260 viral RNA-positive patients.
During the 3 years, 3,014/6,786 (44.4%, 41.4-49.9%) suspected cases were diagnosed as dengue. Use of either NS1 or IgM would have missed 25.5% or 43% of the confirmed dengue cases, respectively. Notably, a higher proportion of secondary dengue cases remained mild while a substantial proportion of primary infections developed warning signs. The symptoms among Dengue/non-dengue patients and primary/secondary infections varied and influenced by age and serostatus. The number and proportion of dengue serotypes varied yearly. A remarkable decline in dengue cases was observed during the COVID-19 pandemic years.
A substantial proportion of primary and secondary dengue patients progress to warning signs/severity or mild infection respectively, underscoring the possible role of non-ADE mechanisms in causing severe dengue that requires hospitalization. Both NS1 and IgM should be used for efficient diagnosis.
了解登革热疾病的动态,特别参考(1)年龄(2)初次/二次感染(3)血清状态和(4)连续三年检查的血清型。
在三个登革热季节(2017-19 年)期间,印度浦那市的 15 个行政区之一使用 NS1/IgM ELISA 进行登革热诊断。在诊断/住院时记录了预定的症状。使用 IgG 捕获 ELISA(Panbio)来区分初次/二次感染。对 260 例病毒 RNA 阳性患者进行 DENV 血清型确定。
在 3 年中,3014/6786(44.4%,41.4-49.9%)疑似病例被诊断为登革热。单独使用 NS1 或 IgM 将分别错过 25.5%或 43%的确诊登革热病例。值得注意的是,较高比例的二次登革热病例仍为轻度,而相当一部分初次感染出现了警告症状。登革热/非登革热患者以及初次/二次感染之间的症状因年龄和血清状态而异。登革热血清型的数量和比例每年都有所不同。在 COVID-19 大流行期间,登革热病例数量显著下降。
相当一部分初次和二次登革热患者分别进展为警告症状/严重程度或轻度感染,这强调了非 ADE 机制在导致需要住院治疗的严重登革热中的可能作用。应同时使用 NS1 和 IgM 进行有效的诊断。